Cargando…
A Ligand Peptide Motif Selected from a Cancer Patient Is a Receptor-Interacting Site within Human Interleukin-11
Interleukin-11 (IL-11) is a pleiotropic cytokine approved by the FDA against chemotherapy-induced thrombocytopenia. From a combinatorial selection in a cancer patient, we isolated an IL-11-like peptide mapping to domain I of the IL-11 (sequence CGRRAGGSC). Although this motif has ligand attributes,...
Autores principales: | Cardó-Vila, Marina, Zurita, Amado J., Giordano, Ricardo J., Sun, Jessica, Rangel, Roberto, Guzman-Rojas, Liliana, Anobom, Cristiane D., Valente, Ana P., Almeida, Fábio C. L., Lahdenranta, Johanna, Kolonin, Mikhail G., Arap, Wadih, Pasqualini, Renata |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565473/ https://www.ncbi.nlm.nih.gov/pubmed/18941632 http://dx.doi.org/10.1371/journal.pone.0003452 |
Ejemplares similares
-
Display technologies: Application for the discovery of drug and gene delivery agents()
por: Sergeeva, Anna, et al.
Publicado: (2006) -
Ligand-directed Cancer Gene Therapy to Angiogenic Vasculature
por: Driessen, Wouter H.P., et al.
Publicado: (2009) -
Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting
por: Staquicini, Daniela I., et al.
Publicado: (2017) -
Bottom-Up Assembly of Hydrogels from Bacteriophage and Au Nanoparticles: The Effect of Cis- and Trans-Acting Factors
por: Souza, Glauco R., et al.
Publicado: (2008) -
Peptidase Substrates via Global Peptide Profiling
por: Tagore, Debarati M., et al.
Publicado: (2008)